Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352534
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-24
First Post:
2006-07-13
Brief Title:
Vincristine Dactinomycin and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I Stage II or Stage III Wilms Tumor
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Organization Data
Organization:
Childrens Oncology Group
Class:
NETWORK
Study ID:
AREN0532
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |